Julien Blouin

Stock Analyst at Goldman Sachs

(3.30)
# 3,123
Out of 5,182 analysts
30
Total ratings
59.09%
Success rate
2.39%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Apr 17, 2026
Maintains: Sell
Price Target: $39$35
Current: $34.54
Upside: +1.33%
Janus Living
Apr 14, 2026
Initiates: Neutral
Price Target: $27
Current: $24.85
Upside: +8.65%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $16.20
Upside: +4.94%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $341.87
Upside: +19.05%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $101.60
Upside: +4.33%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $30.30
Upside: +22.11%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $14.39
Upside: +38.99%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $30.70
Upside: +2.61%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $27.23
Upside: +57.91%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $16.42
Upside: +3.53%
Maintains: Neutral
Price Target: $165$145
Current: $109.55
Upside: +32.36%
Initiates: Buy
Price Target: $176
Current: $146.22
Upside: +20.37%
Initiates: Neutral
Price Target: $318
Current: $256.83
Upside: +23.82%
Initiates: Neutral
Price Target: $81
Current: $62.32
Upside: +29.97%
Initiates: Buy
Price Target: $187
Current: $125.39
Upside: +49.13%